Commonwealth Equity Services
OGEN icon

Commonwealth Equity Services’s Oragenics OGEN Stock Holding History

Commonwealth Equity Services’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6
Closed -$6K – 3105
2020
Q2 		$6K Buy
+6
New +$5.9K ﹤0.01% 2946

Other funds holding OGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBF
Sara-Bay Financial Sarasota, Florida $375M AUM 56.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Commonwealth Equity Services's OGEN Position: Q3 2020 in Review

Commonwealth Equity Services sold out of Oragenics (OGEN) in Q3 2020, closing a stake of 6 shares — an estimated $6K sold.

Commonwealth Equity Services first reported a position in OGEN in Q2 2020 and held it in 1 quarter. The position peaked at $6K in Q2 2020. 16 funds tracked by Wall St. Rank hold OGEN as of Q3 2020.

  • Commonwealth Equity Services reported no remaining Oragenics position as of Q3 2020 after selling out during the quarter.
  • Commonwealth Equity Services sold 6 Oragenics shares in Q3 2020, an estimated $6K.
  • Commonwealth Equity Services first reported a position in Oragenics in Q2 2020 and held it in 1 quarter.
  • Commonwealth Equity Services's Oragenics position peaked at $6K in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Oragenics as of Q3 2020.

Based on Commonwealth Equity Services's 13F filing for Q3 2020, filed 5 Nov 2020.